BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35355563)

  • 1. Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma.
    Wang Y; Yu X; Huang Y
    Front Endocrinol (Lausanne); 2022; 13():853878. PubMed ID: 35355563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pheochromocytoma/paraganglioma-associated cardiomyopathy.
    Szatko A; Glinicki P; Gietka-Czernel M
    Front Endocrinol (Lausanne); 2023; 14():1204851. PubMed ID: 37522121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAKOTSUBO-LIKE CARDIOMYOPATHY IN A LARGE COHORT OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA.
    Gagnon N; Mansour S; Bitton Y; Bourdeau I
    Endocr Pract; 2017 Oct; 23(10):1178-1192. PubMed ID: 28704094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Complications in Pheochromocytoma and Paraganglioma: Does Phenotype Matter?
    Petrák O; Krátká Z; Holaj R; Zítek M; Nguyen Nikrýnová T; Klímová J; Kološová B; Waldauf P; Michalský D; Novák K; Markvartová A; Zlatohlávek L; Grus T; Dušková J; Widimský J; Zelinka T
    Hypertension; 2024 Mar; 81(3):595-603. PubMed ID: 38152977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine-Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease?
    Santos JRU; Brofferio A; Viana B; Pacak K
    Horm Metab Res; 2019 Jul; 51(7):458-469. PubMed ID: 30227459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma.
    Zhang L; Åkerström T; Mollazadegan K; Beuschlein F; Pacak K; Skogseid B; Crona J
    Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37185155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma.
    Lopez C; Bima C; Bollati M; Bioletto F; Procopio M; Arata S; Candela DG; Beccuti G; Ghigo E; Maccario M; Parasiliti-Caprino M
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.
    Parasiliti-Caprino M; Lucatello B; Lopez C; Burrello J; Maletta F; Mistrangelo M; Migliore E; Tassone F; La Grotta A; Pia A; Reimondo G; Giordano R; Giraudo G; Piovesan A; Ciccone G; Deandreis D; Limone P; Orlandi F; Borretta G; Volante M; Mulatero P; Papotti M; Aimaretti G; Terzolo M; Morino M; Pasini B; Veglio F; Ghigo E; Arvat E; Maccario M
    Hypertens Res; 2020 Jun; 43(6):500-510. PubMed ID: 31586159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal arterial remodeling in patients with pheochromocytoma or paraganglioma and its reversibility following surgical treatment.
    Gosk-Przybyłek M; Doroszko A; Dobrowolski P; Warchoł-Celińska E; Harazny J; Bińczyk E; Szymanek K; Pęczkowska M; Kabat M; Toutounchi S; Gałązka Z; Górnicka B; Szaflik J; Januszewicz M; Klisiewicz A; Hoffman P; Lenders JWM; Eisenhofer G; Szaflik JP; Schmieder RE; Prejbisz A; Januszewicz A
    J Hypertens; 2020 Aug; 38(8):1551-1558. PubMed ID: 32205562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant Paraganglioma Complicated With Catecholamine Crisis and Catecholamine Cardiomyopathy: A Case Report and Review of the Literature.
    Ma X; Chen Z; Xia P; Zhang C; Yan K; Fan Y; Wang Y; Ti Y; Bu P
    Front Endocrinol (Lausanne); 2021; 12():790080. PubMed ID: 35185782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
    Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
    Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic biomarkers of life-threatening pheochromocytoma-induced cardiomyopathy.
    Amar J; Brunel J; Cardot Bauters C; Jacques V; Delmas C; Odou MF; Savagner F
    Endocr Relat Cancer; 2022 Apr; 29(5):267-272. PubMed ID: 35258481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes.
    Cui Y; Ma X; Gao Y; Chang X; Chen S; Lu L; Tong A
    Front Endocrinol (Lausanne); 2021; 12():762548. PubMed ID: 34899602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series.
    Deljou A; Kohlenberg JD; Weingarten TN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
    BMC Anesthesiol; 2018 Nov; 18(1):158. PubMed ID: 30400849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature.
    Zhang R; Gupta D; Albert SG
    Int J Cardiol; 2017 Dec; 249():319-323. PubMed ID: 29121733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
    Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
    J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical Review.
    Batisse-Lignier M; Pereira B; Motreff P; Pierrard R; Burnot C; Vorilhon C; Maqdasy S; Roche B; Desbiez F; Clerfond G; Citron B; Lusson JR; Tauveron I; Eschalier R
    Medicine (Baltimore); 2015 Dec; 94(50):e2198. PubMed ID: 26683930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome.
    Y-Hassan S; Falhammar H
    Endocrine; 2019 Sep; 65(3):483-493. PubMed ID: 31399912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the effect of catecholamines on diastolic function in patients with pheochromocytoma and paraganglioma?
    Macedo TA; Drager LF; Vieira MLC
    J Clin Ultrasound; 2023 Jan; 51(1):36-37. PubMed ID: 36468283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.